Study of bone marrow immune cells in chronic myelomonocytic leukemia
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at certain immune cells called macrophages in the bone marrow of people with chronic myelomonocytic leukemia (CMML). It aims to better understand the disease, which may help improve treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 55 years of age or older.
- You have been diagnosed with chronic myelomonocytic leukemia (CMML).
- You are able to provide a bone marrow sample during a routine visit.
- You have not had chemotherapy or immunosuppressive treatment in the last 4 weeks.
- You do not have an active infection or inflammatory condition.
- You are not under legal guardianship or protection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study examines blood cells from patients with chronic myelomonocytic leukemia (CMML), a rare blood cancer, to better understand how the disease develops and progresses. By studying your blood cells, researchers hope to learn more about what causes CMML and how to treat it better.
This study looks at certain proteins in the blood (called FLT3 ligand and IL6) of people being treated for blood cancers like AML, MDS, or CMML. The goal is to understand how these proteins change during non-intensive chemotherapy, which may help doctors better personalize treatment.
This research study collects information from adults with chronic myelomonocytic leukemia (CMML), a rare blood cancer where the body makes too many monocytes (a type of white blood cell). By following patients over time, researchers aim to better understand the disease and improve treatments.
This study looks at how your 'biological age' (how old your body seems) affects how well you do on targeted therapy for chronic myeloid leukemia. It aims to personalize your care by combining age and frailty information.
This study is looking at how a certain biological pathway (called BMP) affects the progression of blood cancers like MDS and AML. By understanding this, doctors hope to find better ways to predict or treat these conditions.
This study looks at immune cells (monocytes) in people with certain blood cancers. Researchers want to understand how these cells behave and change over time. You can join if you are newly diagnosed and haven't started treatment yet.
Hear when a new Chronic Myelomonocytic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.